N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Kentucky Women's Justice Community Overdose Innovation Network - Phase II

Sponsor: Michele Staton • ClinicalTrials.gov ID: NCT07179614

Registry updated: 2026-09-16
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.

Interventions

  • Overdose Prevention Intervention Package (OPIP) (Behavioral)
    WJCOIN-II's multi-level 2 X 2 randomized factorial design will examine the effectiveness of OPIP components across four study conditions randomly assigned after baseline data collection (n=75 per condition, 100 per jail site), summarized in Table 7 and described below. In addition to group assignment, outcomes will be assessed as a function of engagement in each intervention component defined as the number of sessions attended (RC and CM conditions) and perceived support, which is a count of the number of types of support provided by the RC and SP (e.g., emotional, financial, etc.).

Eligibility criteria

Inclusion Criteria: * DSM-5 scores of 2+ for opioids (OUD) and/or stimulants (StUD), * no evidence of cognitive impairment in providing consent, * a release date within 7-60 days to allow for time for intervention sessions, * willingness to consider SUD treatment post-release, and * willingness to provide the name and contact information of at least one person in the community who will support the woman's recovery pre/post-release (SP). Exclusion Criteria: * Not living in a rural area * Any condition that would not allow capable informed consent

Conditions

Overdose Risk Opioid Use Disorder Stimulant Use Disorders

Locations

  • Knox County Detention Center — Barbourville, Kentucky, United States
  • Harlan County Detention Center — Harlan, Kentucky, United States
  • Leslie County Detention Center — Hyden, Kentucky, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record